Bayer Animal Health

Animal health innovation and delivery

About Bayer Animal Health

A leading global animal health company with 166 years of experience focused on innovation, value creation, and customer-centered solutions

Tiermedizin: Adivo und Bayer verkünden Partnerschaft
Adivo GmbH and Bayer Animal Health GmbH are collaborating globally to develop therapeutic antibodies for veterinary medicine, focusing on innovative pet treatments.
munich-startup.de · Aug 1, 2026
Animal Health Market Intelligence Report 2026-2034 Featuring Strategic Analysis of Bayer, Elanco, Merck, Merial, Zoetis, Boehringer Ingelheim, Ceva Sante Animale, Heska and More
The animal health market is expanding due to increased awareness of zoonotic diseases, technological advancements in treatments and diagnostics, and the growing trend of pet humanization.
finance.yahoo.com · Apr 16, 2026
Bayer verkauft Tierarznei-Sparte
Bayer is divesting its profitable Animal Health division to Elanco for 6.8 billion euros to reduce corporate debt.
radioleverkusen.de · Apr 1, 2026
Decoding Elanco Animal Health Inc (ELAN): A Strategic SWOT Insig
Elanco Animal Health Inc. published its 10-K report, highlighting its global market presence, diverse product portfolio, and strategic acquisitions while addressing regulatory hurdles and competitive pressures.
gurufocus.com · Mar 12, 2026
PetMed, Elanco, Tractor Supply Settle Flea & Tick Med Claims
Elanco, PetMed Express, and Tractor Supply settled a lawsuit alleging they blocked generic flea and tick medications from the market.
law360.com · Feb 27, 2026

Bayer Animal Health is a B2B/B2C company in the Veterinary industry, headquartered in Monheim, North Rhine-Westphalia, Germany.

Bayer Animal Health has 251–1,000 employees.

Bayer Animal Health's revenue is $32.6M – $120M (Tamtam estimate).

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.